
Galaxy Oncology Associates Private Limited
Establishing cancer care facilities in northern India through trading medicine and shares.
Establishing cancer care facilities in northern India through trading medicine and shares.
Galaxy Oncology Associates Private Limited (GOAPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 October 2006 and has a history of 18 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.62 Cr.
The company currently has active open charges totaling ₹3.50 Cr. The company has closed loans amounting to ₹12.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Umang Mithal, Pragati Agarwal, and Sachin Kumar serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U85110DL2006PTC154903
154903
Private Limited Indian Non-Government Company
19 Oct 2006
27 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pragati Agarwal ![]() | Managing Director | 28-Mar-2017 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Umang Mithal ![]() | Director | 08-Aug-2022 | Current |
Sachin Kumar ![]() | Director | 29-Dec-2022 | Current |
Galaxy Oncology Associates Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.36% decrease. The company also saw a substantial fall in profitability, with a 1544.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.94%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Galaxy Oncology Associates had a promoter holding of 50.13% and a public holding of 49.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Umang Mithal is a mutual person
Umang Mithal is a mutual person
Pragati Agarwal is a mutual person
₹3.50 Cr
₹12.00 Cr
Date | Lender | Amount | Status |
---|---|---|---|
01 Feb 2023 | Others | ₹1.60 Cr | Open |
20 Sep 2022 | Others | ₹1.90 Cr | Open |
15 Dec 2007 | Bank Of India | ₹12.00 Cr | Satisfied |
Unlock and access historical data on people associated with Galaxy Oncology Associates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Galaxy Oncology Associates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galaxy Oncology Associates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Galaxy Oncology Associates Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
Galaxy Oncology Associates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
A charge with Others amounted to Rs. 1.60 Cr with Charge ID 100686837 was registered on 01 Feb 2023.
Sachin Kumar was appointed as a Director was appointed as a Director on 29 Dec 2022 & has been associated with this company since 2 years 4 months .
A charge with Others amounted to Rs. 1.90 Cr with Charge ID 100644247 was registered on 20 Sep 2022.
Umang Mithal was appointed as a Director was appointed as a Director on 08 Aug 2022 & has been associated with this company since 2 years 8 months .
Galaxy Oncology Associates Private Limited was incorporated on 19 Oct 2006.
The authorized share capital of Galaxy Oncology Associates Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 3.62 Cr.
Currently 3 directors are associated with Galaxy Oncology Associates Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Galaxy Oncology Associates Private Limited is Unit No. 302 Third Floor Plot 9 Vardhman Siddhant Plaza L.S.C. Savita V Ihar, India, Delhi, 110092.
The corporate identification number (CIN) of Galaxy Oncology Associates Private Limited is U85110DL2006PTC154903 and the company number is 154903 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Galaxy Oncology Associates Private Limited has fallen by -21.36%.
The financial reports for the fiscal year 2023 indicates that The net worth of Galaxy Oncology Associates Private Limited has experienced an downturn of -46.94%.
As per the financial statements for fiscal Year 2023, The total open charges for Galaxy Oncology Associates Private Limited amount to ₹ 3.50 Cr.
The most recent Balance Sheet for Galaxy Oncology Associates Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
AG
MN
SA
KG
SD
AV